MMP2 and urinary bladder cancer: The upregulation of cytokeratin 18 and cytokeratin 19 (epithelial markers) and the downregulation of vimentin, N-cadherin, MMP2, and ZEB1 (mesenchymal markers) were observed in the bone metastatic T24-B bladder cancer cells.